Angiogenesis and anti-angiogenesis in hepatocellular carcinoma
- 作者Domenico Ribatti; Angelo Vacca; Beatrice Nico; Domenico Sansonno; Franco Dammacco
- 卷第32卷
- 期第6期
- 印刷ISSN0305-7372
- 文件大小197.88KB
- 发表时间2006
- DOI10.1016/j.ctrv.2006.06.002
Management of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate CancerRago, Randall · Cancer Control · 1998
MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTSOH, WILLIAM K.; KANTOFF, PHILIP W. · The Journal of Urology · 1998
Endocrine Withdrawal Syndrome and Its Relevance to the Management of Hormone Refractory Prostate CancerKelly, W.K. · European Urology · 1998
879 Docetaxel (DOC) and mitoxantrone (MIT) in the management of hormone-refractory prostate cancerA. Heidenreich; C. Ohlmann; P. Olbert; A. Hegele · 2003
306 DOCETAXEL (DOC) AND MITOXANTRON (MIT) IN THE MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER (HRPCA)C.H. Ohlmann; K. Breitenbach; D. Pfister; U. Engelmann; A. Heidenreich · 2007
613 Docetaxel (DOC) and mitoxantrone (MIT) in the management of hormone refractory prostate cancer (HRPCA)A. Heidenreich; A. Schrader; P. Olbert; C. Ohlmann; A. Hegel; R. Hofmann · 2004
Severe hypophosphatemic osteomalacia in hormone-refractory prostate cancer metastatic to the skeleton: natural history and pitfalls in managementRob C.M. Pelger; Guus A.B. Lycklama À Nijeholt; Socrates E. Papapoulos; Neveen A.T. Hamdy · 2005
Systemic Chemotherapy for Urothelial CancerGuru Sonpavde; Thomas E. Hutson; William R. Berry · 2006
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancerGuru Sonpavde; Kim N. Chi; Thomas Powles; Christopher J. Sweeney; Noah Hahn; Thomas E. Hutson; Matthew D. Galsky; William R. Berry; Dov Kadmon · 2007
Phase II Study of Azacitidine to Restore Responsiveness of Prostate Cancer to Hormonal TherapyGuru Sonpavde; Ana Aparicio; Israel Guttierez; Kristi A. Boehm; Thomas E. Hutson; William R. Berry; Lina Asmar; Daniel D. von Hoff · 2007
Phase II Trial of Sunitinib for the Therapy of Progressive Metastatic Castration-Refractory Prostate Cancer After Previous Docetaxel ChemotherapyGuru Sonpavde; Thomas E. Hutson; William R. Berry; Kristi A. Boehm; Lina Asmar · 2008
Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate CancerMark T. Fleming; Guru Sonpavde; Michael Kolodziej; Sanjay Awasthi; Thomas E. Hutson; Danko Martincic; Ashutosh Rastogi; Steven R. Rousey; Ralph E. Weinstein; Matthew D. Galsky; William R. Berry; Yunfei Wang; Kristi A. Boehm; Lina Asmar; Mary A. Rauch; Tomasz M. Beer · 2012